YAP, a key effector of Hippo pathway, is activated by its translocation from cytoplasm to nucleus to regulate gene expression and promote tumorigenesis. Although the mechanism by which YAP is suppressed in cytoplasm has been well-studied, how the activated YAP is sequestered in the nucleus remains unknown. Here, we demonstrate that YAP is a nucleocytoplasmic shuttling protein and its nuclear export is controlled by SET1A-mediated mono-methylation of YAP at K342, which disrupts the binding of YAP to CRM1. YAP mimetic methylation knockin mice are more susceptible to colorectal tumorigenesis. Clinically, YAP K342 methylation is reversely correlated with cancer survival. Collectively, our study identifies SET1A-mediated mono-methylation at K342 as an essential regulatory mechanism for regulating YAP activity and tumorigenesis.
Pubmed ID: 30008322 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets beta Actin
View all literature mentionsThis monoclonal targets HA tag antibody [HA.C5]
View all literature mentionsThis polyclonal targets CRM1
View all literature mentionsThis polyclonal targets hSET1
View all literature mentionsThis polyclonal targets hSET1B
View all literature mentionsThis monoclonal targets V5 Tag
View all literature mentionsThis monoclonal targets FLAG
View all literature mentionsThis polyclonal targets DPY30 antibody
View all literature mentionsThis monoclonal targets ASH2L antibody [2046D2a]
View all literature mentionsThis polyclonal targets RBBP5
View all literature mentionsThis monoclonal targets WDR5
View all literature mentionsThis monoclonal targets Histone H3
View all literature mentionsThis polyclonal targets Lamin A/C
View all literature mentionsThis monoclonal targets GAPDH
View all literature mentionsThis polyclonal targets CTGF
View all literature mentionsThis monoclonal targets Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204)
View all literature mentionsThis monoclonal targets p44/42 MAPK (Erk1/2)
View all literature mentionsThis monoclonal targets Ki-67
View all literature mentionsThis polyclonal targets LATS1 +LATS2 (phospho T1079 + T1041) antibody
View all literature mentionsThis polyclonal targets LATS2 antibody
View all literature mentionsThis monoclonal targets LATS1
View all literature mentionsThis polyclonal targets YAP1
View all literature mentionsThis recombinant monoclonal targets YAP
View all literature mentionsOpen source Java based image processing software program designed for scientific multidimensional images. ImageJ has been transformed to ImageJ2 application to improve data engine to be sufficient to analyze modern datasets.
View all literature mentionsStatistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.
View all literature mentionsThis monoclonal targets beta Actin
View all literature mentions